Oramed Pharmaceuticals Inc logo

Oramed Pharmaceuticals Inc

$ 8.65 +0.31 (+3.72%) 10:08 PM EST
P/E:
At Loss
P/B:
2.20
Market Cap:
$ 338.34M
Enterprise V:
$ 179.69M
Volume:
251.66K
Avg Vol (2M):
258.04K
Also Trade In:
Volume:
251.66K
Market Cap $:
338.34M
PE Ratio:
At Loss
Avg Vol (2-Month):
258.04K
Enterprise Value $:
179.69M
PB Ratio:
2.20
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.
Name Current Vs Industry Vs History
Cash-To-Debt 177.28
Equity-to-Asset 0.94
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 17.06
Distress
Grey
Safe
Beneish M-Score -3.16
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 67.77
9-Day RSI 63.85
14-Day RSI 61.63
6-1 Month Momentum % 42.22
12-1 Month Momentum % -61.93

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 24.55
Quick Ratio 24.55
Cash Ratio 24.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.1

Financials (Next Earnings Date:2023-01-11 Est.)

ORMP's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:ORMP

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.696
EPS (TTM) ($) -0.94
Beta 2.47
Volatility % 122.21
14-Day RSI 61.63
14-Day ATR ($) 0.637937
20-Day SMA ($) 7.731
12-1 Month Momentum % -61.93
52-Week Range ($) 3.59 - 17.64
Shares Outstanding (Mil) 39.11

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Oramed Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Oramed Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.